WO2012092508A2 - Vaginal remodeling/rejuvenation device and method - Google Patents

Vaginal remodeling/rejuvenation device and method Download PDF

Info

Publication number
WO2012092508A2
WO2012092508A2 PCT/US2011/067938 US2011067938W WO2012092508A2 WO 2012092508 A2 WO2012092508 A2 WO 2012092508A2 US 2011067938 W US2011067938 W US 2011067938W WO 2012092508 A2 WO2012092508 A2 WO 2012092508A2
Authority
WO
WIPO (PCT)
Prior art keywords
optical fiber
vagina
genitalia
treatment system
medical treatment
Prior art date
Application number
PCT/US2011/067938
Other languages
French (fr)
Other versions
WO2012092508A3 (en
Inventor
Gabriel FEMOPASE
Original Assignee
Ceramoptec Industries, Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ceramoptec Industries, Inc. filed Critical Ceramoptec Industries, Inc.
Priority to EP11852256.4A priority Critical patent/EP2658465B1/en
Priority to CN2011800638337A priority patent/CN103281984A/en
Priority to MX2013007234A priority patent/MX349589B/en
Priority to AU2011352059A priority patent/AU2011352059A1/en
Priority to BR112013016337A priority patent/BR112013016337A2/en
Priority to US13/997,554 priority patent/US10687894B2/en
Publication of WO2012092508A2 publication Critical patent/WO2012092508A2/en
Publication of WO2012092508A3 publication Critical patent/WO2012092508A3/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B18/00Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
    • A61B18/18Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by applying electromagnetic radiation, e.g. microwaves
    • A61B18/20Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by applying electromagnetic radiation, e.g. microwaves using laser
    • A61B18/22Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by applying electromagnetic radiation, e.g. microwaves using laser the beam being directed along or through a flexible conduit, e.g. an optical fibre; Couplings or hand-pieces therefor
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B18/00Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
    • A61B2018/00053Mechanical features of the instrument of device
    • A61B2018/00184Moving parts
    • A61B2018/00196Moving parts reciprocating lengthwise
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B18/00Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
    • A61B2018/00315Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body for treatment of particular body parts
    • A61B2018/00559Female reproductive organs
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B18/00Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
    • A61B2018/00571Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body for achieving a particular surgical effect
    • A61B2018/00577Ablation
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B18/00Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
    • A61B2018/00982Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body combined with or comprising means for visual or photographic inspections inside the body, e.g. endoscopes
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B18/00Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
    • A61B18/18Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by applying electromagnetic radiation, e.g. microwaves
    • A61B18/20Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by applying electromagnetic radiation, e.g. microwaves using laser
    • A61B2018/2035Beam shaping or redirecting; Optical components therefor
    • A61B2018/20361Beam shaping or redirecting; Optical components therefor with redirecting based on sensed condition, e.g. tissue analysis or tissue movement
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B18/00Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
    • A61B18/18Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by applying electromagnetic radiation, e.g. microwaves
    • A61B18/20Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by applying electromagnetic radiation, e.g. microwaves using laser
    • A61B18/22Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by applying electromagnetic radiation, e.g. microwaves using laser the beam being directed along or through a flexible conduit, e.g. an optical fibre; Couplings or hand-pieces therefor
    • A61B2018/2255Optical elements at the distal end of probe tips
    • A61B2018/2272Optical elements at the distal end of probe tips with reflective or refractive surfaces for deflecting the beam

Definitions

  • the present invention relates to devices and medical treatments for medical and aesthetic conditions of female genitalia. More particularly, it relates to optical fiber and laser systems and methods used for the treatment of various medical and aesthetic conditions of female genitalia such as female sexual dysfunction (FSD).
  • FSD female sexual dysfunction
  • Sexuality occupies an important part in the lives of adult men and women. It is an important health issue that affects the quality of life of many women and their partners across the world. Almost 50% of women report sexual problems at some point in their life. They may have difficulty or have lost their ability to achieve an orgasm. Some experience discomfort or even pain during sex. Many are unsatisfied with the external looks of their genitalia.
  • Vaginal relaxation is a condition in which the vaginal muscles become relaxed, loosing tone, strength, control and support.
  • the internal and external vaginal diameters can greatly increase.
  • sexual response defined as a set of psychological, neurophysiological, vascular and hormonal changes that take place when engaging in sexual acts, diminishes due to a reduction of sexual feelings and pleasure.
  • other physiological problems commonly arise, such as vaginal prolapse and consequently urinary incontinence.
  • Publication 2004/0059190 by Matlock discloses a method of colpoplasty directed to augmentation of the Grafenberg Spot area.
  • One preferred embodiment of temporary colpoplasty uses injectable collagen obtained from a tissue bank.
  • One embodiment of a permanent colpoplasty uses implantable grade Expanded Polytetrafluoro ethylene (ePTFE). This approach does not address the problem of an augmented diameter of vagina and therefore condition persists.
  • ePTFE Expanded Polytetrafluoro ethylene
  • Labiaplasty involves the removal of a portion of the hypertrophied labia minora and the occasionally enlarged and redundant labia majora.
  • Clitoral hood reduction involves a size reduction of redundant or hypertrophic clitoral hood folds for cosmetic reasons or less frequently, for separation of a phimotic hood to provide more exposure of the clitoral glands to provide improved sensation.
  • Perineoplasty is the surgical reconstruction of the vulvar vestibule, vaginal introitus, and distal vagina, whereby scarred and redundant tissue is excised, the opening attenuated, and the superficial transverse perineal and levator musculature reapproximated in the midline to elevate the perineum and pelvic floor.
  • Vaginoplasty involves the excision of portions of mucosa from the vaginal fornices to tighten a relatively lax upper vagina.
  • Penetration of 980 nm and 10.6 mm wavelengths to inner capillaries is undesirable when target tissue is on the surface.
  • Another disadvantage of prior art is that currently used optical fibers emit in a forward direction. This limits physician in capability of accurate access to, for example, lateral walls inside vagina. Accuracy needs to be enhanced in order to decrease possibility of reported post-operative complications, such as infection, altered sensitivity, dyspareunia, adhesions, and scarring.
  • US Patent Application Publication No. 2007-0233191 by Parmer discloses a device and method of tightening tissue of the female genitalia by heating targeted connective tissue with radiant energy, while cooling the mucosal epithelial surface over the target tissue to protect it from the heat.
  • the tip cools the mucosa by contact, and delivers energy through the epithelium to the underlying tissue, creating a reverse thermal gradient.
  • the desired effect is to remodel genital tissue by tightening it.
  • Such remodeling may include a tighter vagina and a tighter introitus as a consequence of thermal denaturation of collagen as well as a longer term healing response in the tissue that includes an increased deposition of collagen.
  • the types of energy delivery element may include a radiofrequency, microwave or ultrasound delivery. Mentioned types of energy are not ideal for treatment of female genitalia. They present several disadvantages in comparison with laser energy, related to precision and their effects on target tissue. Laser energy offers more accuracy, better coagulation effects and minimizes the need for cooling the mucosal epithelial surface this invention proposes.
  • a safe accurate and effective treatment system is needed for carrying out surgical ablation procedures to improve anatomical and physiological aspects of a woman's genitalia.
  • Device comprises a laser energy source which conveys laser energy through an optical fiber handpiece.
  • a cylindrical or penis shaped device or applicator for insertion into the vagina, specially designed for safe and accurate irradiation of determined parts of vaginal mucosa is presented.
  • Applicator has an inner hollow path through which optical fiber can be inserted to irradiate inner vaginal tissue. Irradiated mucous tissue contracts and vaginal radius is reduced and it thus can embrace penis in a tighter manner when penetration during sexual intercourse takes place. Consequently, sensitivity is substantially improved and sexual intercourse results more pleasurable for both the woman and her partner.
  • a diode laser source is used emiting at 1470 nm.
  • vagina's outer dimensions are accurately measured and surgery is performed to achieve dimensions according to certain aesthetic and functional criteria. Present method and device causes minimum pain and risk of side effects. Procedure is ambulatory and can be carried out in a physician's office.
  • FIG. 1 Depicts a diagram of a preferred embodiment of present invention showing main comprising parts of laser system.
  • FIG. 2 Shows a diagram of one embodiment of special applicator device for irradiation within the vagina.
  • FIG. 3 Represents the "clock needle” positions of the tissue to be treated.
  • FIG. 4 Shows a diagram of another embodiment of special applicator devi ce for irradiation within the vagina.
  • FIG. 5 Illustrates the geometric relationship that defines the Golden Ratio.
  • FIG. 6 Illustrates an example of the ideal location of the clitoris hood as a function of other parts of the female vagina.
  • the present invention comprises a series of medical devices and treatments performed on the inside and the outside of a woman's vagina, based on the patient ' s expectations concerning quality of life, considering her physical health, psychological state, level of independence and social relations.
  • Treatment is aimed mainly at women who have lost the normal shape of her genitals due to complicated labor, muscular dehiscence, or muscular tear, leading to loss of normal physiological conditions and a considerably decreased sexual response.
  • Treatment is also aimed at women who wish to increase their self-esteem by aesthetically improving the looks of their vagina. Devices, method and criteria to achieve this are proposed without the drawbacks and limitations present in prior art.
  • vaginal prolapse Another important medical condition suffered by women with relaxed vaginas is vaginal prolapse, which can lead to other complications such as urinary incontinence. Applying laser energy within the vagina causes retraction of the mucosa, reducing its diameter by 15-20%. If the right energy is applied in certain places, it enhances pleasure during sexual intercourse or improves conditions like vaginal prolapse.
  • controlled vaginal hyperthermia with a fiber optic medical treatment system is applied to enhance sexual gratification on women who for whatever reason lack an overall optimum architectural integrity of the vagina.
  • Figure 1 depicts a laser based system 100 comprising laser source 102 which emits at a suitable wavelength through fiber optics device 104 radiating from its distal end 106 essentially perpendicular to the fiber axis.
  • the type of optical fiber emission is chosen according to desired type of effect on tissue precision needed, maneuverability and convenient type of emitting pattern.
  • Fibers used include a 360-degree radial fiber, a side firing fiber, an off-axis fiber or a twister fiber.
  • a cylindrical penis-shaped accessory (applicator device) 108 is inserted inside vagina and is used such that fiber 104 emits radiation from within applicator/dilator 108 to assure accurate, safe and even radiation on vagina wall 110.
  • Technique is preferably carried out with a low energy laser device operating at a preselected laser wavelength of about 1470 + 60 nm.
  • the water content in target tissue assures high absorption of this wavelength and thus desired contraction effects with low energy values.
  • different wavelengths are chosen, such as about 980 + 30 nm when, for example deeper tissue penetration is desired. Combinations of these two wavelengths as an example are beneficial when ablation and effectively deeper treatment of the tissue is needed in rejuvenation or corrective surgery.
  • Applicator 200 comprises a specially designed cylindrical element, round-shaped or penis-shaped at insertion end 212 for easy placement into a vagina and a flat end at maneuvering end 214 preferably with a flap handle 216 for easy handling-
  • Applicator 200 is longitudinally hollowed in the middle forming an inner hollow tube 218 such that an optical fiber 204 may be inserted up to about 7 cm into it.
  • vagina's internal mucous lining 210 (tunica mucosa) is irradiated from the inside using a side-firing fiber 204 at a 1470 nm wavelength at desired portions while avoiding irradiation of sensitive parts.
  • inner tube 218 has a non-circular section, for example elliptical, rectangular or star-shaped.
  • optical fiber is installed inside a hand piece holder with a similar section shape and size. This serves two purposes. First of all, it helps maintain fiber steady when applying radiation. Secondly, it prevents use of other commercially existing fibers not intended for application to this type of treatment, thus assuring patient safety.
  • Figure 3 represents the "clock needle" positions of the circumference 300 from which selected areas are to be irradiated.
  • Target portions are located at 2 o'clock 320, 4 o'clock 322, 8 o'clock 324 and 10 o'clock 326.
  • Portion between 10 o'clock 326 and 2 o'clock 320 must be avoided to protect the bladder.
  • Portion between 4 o ' clock 322 and 8 o'clock 324 must be avoided to protect the intestines.
  • Figure 4a depicts another embodiment of essential applicator instrument of present invention used to assure procedure ca be carried out accurately and safely.
  • Figure 4b represents a cross section of applicator 400. It comprises a specially designed cylindrical element 400, round-shaped or penis-shaped at insertion end 412 for easy placement into vagina and flat at maneuvering end 414 preferably with a flap 416 for easy handling.
  • Applicator 400 is longitudinally hollowed in the middle forming an inner hollow tube 418 such that an optical fiber 404 may be inserted up to about 7 cm into it.
  • a 360-degree radial emitting fiber or a side-firing fiber 404 is preferably used.
  • Applicator 400 is designed such that its surface is transparent to light in places corresponding to target tissue areas 420 but opaque in the rest of the surface so that sensible organs are not reached by laser irradiation.
  • a radial emitting fiber 404 is inserted through applicator 400 made of a material such that light goes through only transparent longitudinal canals 422 but is either reflected or absorbed in the rest of cylinder's internal wall.
  • controlled vaginal hyperthermia (CVH) procedure consists of placing patient in gynecological position and introducing inside vagina an applicator device such as previously described Figure 2 or Figure 4. Next, fiber is introduced up to distal end of area to be treated. Additional elements such as a speculum can be used to aid in properly viewing treated area. Then, dilator is rotated to desired position and proper lasing parameters are set. Finally, laser energy is applied while fiber optic is withdrawn at a predetermined constant speed. After treatment, patient is encouraged to use a vaginal exerciser for a few days after surgery to prevent unwanted tissue collapse.
  • CVH controlled vaginal hyperthermia
  • optical fiber is connected to an automatic pull-back system or device such as a step motor. This allows physician to assure withdrawal speed is constant, making procedure safer and more accurate.
  • applicator comprises an additional channel for insertion of an imaging system such as an endoscopic device, for online, real time monitoring of the procedure.
  • an imaging system such as an endoscopic device
  • An endoscopic device can also be incorporated through use of a shaped inner channel (hollow tube) to position both the endoscope and the fiber relative to one another in the main inner channel
  • the following example describes a device and procedure which has rendered positive tissue retraction results on women patients desiring enhancement of their sexual relations.
  • Applicator is made of solid quartz, 3.5 cm in diameter and 10 cm long. It is flat on one end and rounded (penis-shaped) on the other end. It has a 7 cm long inner elliptical-shaped hollow tube in the middle with a transverse diameter of 2 mm and a conjugate diameter of 1 cm.
  • Hand piece holder with a similar section shape and size and with a side-firing optical fiber fixed inside can fit inside hollow tube but does not allow fiber to rotate.
  • Laser power is set at 10 Watts and emitted while fiber is withdrawn at a rate of 0.33 cm/s with firing end of fiber successively pointing at 4 o'clock, and at 10 o'clock.
  • Endoscopic imaging after treatment showed a 5 mm thick white line along each lased portion of vaginal mucosa.
  • Patient was instructed to not have sexual intercourse for the next 7 days. After a period of 45 days, lased portions retract and thus vaginal diameter is reduced.
  • Vaginoplasty with laser radiation which comprises enhancement of vulvar structures, namely labia minora, labia majora, mons veneris, vaginal aperture and hymen. Examples of treatments that comprise surgery are:
  • Reducti ve labiaplasty and reduction of excess clitoral hood procedures allow for reducing hypertrophy of labia minora, and correcting asymmetric labia.
  • Perineoplasty rejuvenates the perineum which has lost its tone, and improves the sagging labia majora and labia minora. This procedure aims to make the vulva look younger.
  • the device used is similar than the used in earlier examples/descriptions. Practitioners select optimally tipped fibers for use with given applicators and desired irradiation geometry. The power levels are similar for primarily denaturing tissue, though ablation would use somewhat higher power and/or longer exposure to deposit more energy and achieve the desired amount of ablative tissue.
  • vaginal relaxation causes other important medical conditions, such as prolapsed vaginal or pelvic areas, which are also beneficially treated by the present invention.
  • a vaginal prolapse is a condition in which structures such as the uterus, rectum, bladder, urethra, small bowel, or the vagina itself may begin to prolapse, or fall out of their normal positions. Without medical treatment or surgery, these structures may eventually prolapse farther and farther into the vagina or even through the vaginal opening if their supports weaken enough. In their extreme they can become life-threatening.
  • the symptoms that result from vaginal prolapse commonly affect sexual functions and bodily functions such as urination and defecation. Pelvic pressure and discomfort are also common symptoms.
  • Urinary incontinence is a common symptom of this condition.
  • minimally invasive surgery using 1470 nm laser radiation is applied to correct such medical conditions.
  • the overall objective is to treat the vagina so that it recovers its normal anatomy and physiology to achieve normal biological functions, improved external aspects and enhanced sexual gratification.
  • Treatment is ambulatory and lasts a few minutes.
  • Laser technique with 1470 nm or 980 nm wavelength and an off-axis or radially emitting fiber and protective device assures a precise treatment with minimal bleeding, effective scaring and essentially no complications or side effects.
  • Final result is reconstruction of the most important part of the vagina for sexual pleasure, which is its lower third. Muscles and fascia are strengthened, thus improving vaginal muscular tone, strength and control. Excess vaginal mucosa is removed and the internal and external diameters of the vagina are reduced.
  • Two of the enhanced areas are directly or indirectly involved with areas that help produce an orgasm.
  • One is the perineum, which is completely reconstructed, augmenting its potential for producing an orgasm.
  • the other is the superior portion of the orgasmic platform, which contains the G-spot from which intense sexual pressure sensations derive.
  • also named the aurial number, golden number or divine section
  • This concept has been used by historically known geniuses such as Salvador Dali in his paintings and Leonardo Da Vinci in his works.
  • two quantities are in the golden ratio if the ratio of the sum of the quantities to the larger quantity is equal to the ratio of the larger quantity to the smaller one.
  • the golden ratio is an irrational mathematical constant, approximately 1.6180339887.
  • the golden section is a line segment divided according to the golden ratio:
  • the total length a + b is to the longer segment, a, as a is to the shorter segment, b.
  • Figure 6 depicts an example of how, sequentially from A to D the ideal location of the clitoris hood is graphically located as a function of other parts of the female vagina.

Abstract

A device and method for treating a vagina's anatomic, functional and aesthetic conditions are disclosed. Device comprises a laser energy source which conveys laser energy through an optical fiber handpiece. A cylindrical/penis shaped device/applicator for insertion into the vagina is specially designed for safe and accurate irradiation of determined parts of vaginal mucosa. Applicator has an inner hollow path through which optical fiber is inserted to irradiate inner vaginal tissue. Irradiated mucous tissue contracts, thus vaginal radius is reduced and during penetration in sexual intercourse it embraces penis more tightly. Consequently, sensitivity is substantially improved and sexual intercourse is more pleasurable for both the woman and her partner. In an embodiment, the diode laser source emitting at 1470 nm is used. In another embodiment, vagina's outer dimensions are accurately measured and surgery is performed to achieve dimensions according to certain aesthetic and functional criteria. Present method and device cause minimum pain and risk of side effects. Procedure is ambulatory and can be carried out in a physician's office.

Description

Vaginal Remodeling/Rejuvenation Device and Method
Inventor: Gabriel Femopase
Assignee: CeramOptec Industries Inc.
Background of the Invention
Field of the Invention The present invention relates to devices and medical treatments for medical and aesthetic conditions of female genitalia. More particularly, it relates to optical fiber and laser systems and methods used for the treatment of various medical and aesthetic conditions of female genitalia such as female sexual dysfunction (FSD).
State of the Art
Sexuality occupies an important part in the lives of adult men and women. It is an important health issue that affects the quality of life of many women and their partners across the world. Almost 50% of women report sexual problems at some point in their life. They may have difficulty or have lost their ability to achieve an orgasm. Some experience discomfort or even pain during sex. Many are unsatisfied with the external looks of their genitalia.
Aesthetically, there is a historically well known criterio for objectively assessing subjective features, such as beauty and perfection. At least since the Renaissance, many artists and architects have proportioned their works to approximate the golden ratio— especially in the form of the golden rectangle, in which the ratio of the longer side to the shorter is the golden ratio— believing this proportion to be aesthetically pleasing. In the human anatomy, characteristics such as harmony, proportion and symmetry have been considered with this criteria since Leonardo Da Vinci. Leonardo da Vinci's illustrations of polyhedral in De Divina Proportione (On the Divine Proportion) and his views that some bodily proportions exhibit the golden ratio, have led some scholars to speculate that he incorporated the golden ratio in his paintings. However, there are no known works which have applied such criteria or any other criteria to the human external sex organs.
Thus, a method is needed which adopts objective criteria to perform treatments focused on beautifying female genitalia. Vaginal relaxation is a condition in which the vaginal muscles become relaxed, loosing tone, strength, control and support. The internal and external vaginal diameters can greatly increase. Thus, the vagina cannot sexually function as under normal conditions. Sexual response, defined as a set of psychological, neurophysiological, vascular and hormonal changes that take place when engaging in sexual acts, diminishes due to a reduction of sexual feelings and pleasure. Additionally, other physiological problems commonly arise, such as vaginal prolapse and consequently urinary incontinence.
Approaches to correct this are aimed at tightening the vagina's inner tissue and reducing its diameter. Some are related to delivery of liquids into the body and which solidify inside the body to yield a solid or gel to enhance the tension in vaginal tissues and pelvic floor. For instance, US Patent Application 2005/0187429 by Poppas et al presents a tissue reinforcement therapy to make the vaginal vault smaller and possibly increase and/or restore sexual gratification. Therapy involves augmenting the distal third of the vagina, the orgasmic platform, the external vaginal opening and the perineal area with an injectable, in situ polymerizing, liquid. One aspect of the invention involves a surgical adhesive used as a tissue filling or augmentatio medium to decrease the internal diameter of the vagina. The surgical adhesive cures in place in the body to form an elastic, malleable solid capable of displacing tissue and thereby increasing the tone of the vagina. In US Patent 6,165,108 the use of a dumbbell- shaped device for exercising the musculature of the vagina is proposed. US Patent No. 6,469,016 describes the use of prostaglandins and related chemicals to temporarily affect local lubricity and also affect local muscle tone. All of these approaches have proven ineffective and there is no long-lasting effect of the therapy. US Patent Application
Publication 2004/0059190 by Matlock discloses a method of colpoplasty directed to augmentation of the Grafenberg Spot area. One preferred embodiment of temporary colpoplasty uses injectable collagen obtained from a tissue bank. One embodiment of a permanent colpoplasty uses implantable grade Expanded Polytetrafluoro ethylene (ePTFE). This approach does not address the problem of an augmented diameter of vagina and therefore condition persists.
Thus, a treatment is needed to effectively address vaginal relaxation and the negative consequences regarding a woman's sexual response.
Several surgical treatments are offered to women by different aesthetic medical centers, such as labiaplasty, vaginoplasty, perineoplasty, and clitoral hood reduction. Labiaplasty involves the removal of a portion of the hypertrophied labia minora and the occasionally enlarged and redundant labia majora. Clitoral hood reduction involves a size reduction of redundant or hypertrophic clitoral hood folds for cosmetic reasons or less frequently, for separation of a phimotic hood to provide more exposure of the clitoral glands to provide improved sensation. Perineoplasty is the surgical reconstruction of the vulvar vestibule, vaginal introitus, and distal vagina, whereby scarred and redundant tissue is excised, the opening attenuated, and the superficial transverse perineal and levator musculature reapproximated in the midline to elevate the perineum and pelvic floor. Vaginoplasty involves the excision of portions of mucosa from the vaginal fornices to tighten a relatively lax upper vagina.
These procedures require tissue ablation, which is achieved using tools including scalpel, needle electrode, or laser. Currently, laser energy is preferred over electrocautery or manual scalpel. This is due to several advantages observed by currently used 980 nm diode lasers and C02 10.6 mm lasers, namely, wide surgical field for observation, minimum lesion in adjacent tissue allowing for fast cicatrization, minimum risk of complications, minimum percentage of recurrence and essentially immediate homeostasis. However, currently used laser devices present limitations. C02 lasers are large and bulky and have a complex and delicate arrangement of mirrors which are easily displaced. Furthermore their rigid structure does not allow physician to comfortably and accurately point at desired target. Penetration of 980 nm and 10.6 mm wavelengths to inner capillaries is undesirable when target tissue is on the surface. Another disadvantage of prior art is that currently used optical fibers emit in a forward direction. This limits physician in capability of accurate access to, for example, lateral walls inside vagina. Accuracy needs to be enhanced in order to decrease possibility of reported post-operative complications, such as infection, altered sensitivity, dyspareunia, adhesions, and scarring.
US Patent Application Publication No. 2007-0233191 by Parmer discloses a device and method of tightening tissue of the female genitalia by heating targeted connective tissue with radiant energy, while cooling the mucosal epithelial surface over the target tissue to protect it from the heat. As treatment tip contacts the epithelial mucosa, the tip cools the mucosa by contact, and delivers energy through the epithelium to the underlying tissue, creating a reverse thermal gradient. The desired effect is to remodel genital tissue by tightening it. Such remodeling may include a tighter vagina and a tighter introitus as a consequence of thermal denaturation of collagen as well as a longer term healing response in the tissue that includes an increased deposition of collagen. The types of energy delivery element may include a radiofrequency, microwave or ultrasound delivery. Mentioned types of energy are not ideal for treatment of female genitalia. They present several disadvantages in comparison with laser energy, related to precision and their effects on target tissue. Laser energy offers more accuracy, better coagulation effects and minimizes the need for cooling the mucosal epithelial surface this invention proposes.
Thus, a safe accurate and effective treatment system is needed for carrying out surgical ablation procedures to improve anatomical and physiological aspects of a woman's genitalia.
There is thus a need for a treatment system that improves on the state of the art, providing complete, safe, minimally invasive treatment for treating a woman's genitalia to achieve and enhance a woman's sexual expectations considering her vagina's physiological and anatomical condition, sex life and aesthetics. The present invention addresses these needs.
Objectives and Brief Summary of the Invention
It is an objective of the present invention to restore corporal integrity and biological functions of feminine genitalia for a renewed/rejuvenated sexuality that is more satisfactory, safe and pleasurable.
It is another objective of the present invention to provide a device and method of treatment for female sexual dysfunction (FSD).
It is also an objective of the present invention to provide a device and method for aesthetic enhancement of female genitalia.
It is yet another object of this invention to satisfy and enhance sexual gratification in women and their partners who may or may not suffer FSD.
It is still another objective of the present invention to present accurate laser energy to the interior of a woman's vagina to improve its anatomical and physiological characteristics for enhancement of the woman's sex life and that of her sexual partner.
Briefly stated, a device and method for treating a vagina's anatomic, functional and aesthetic conditions are disclosed. Device comprises a laser energy source which conveys laser energy through an optical fiber handpiece. A cylindrical or penis shaped device or applicator for insertion into the vagina, specially designed for safe and accurate irradiation of determined parts of vaginal mucosa is presented. Applicator has an inner hollow path through which optical fiber can be inserted to irradiate inner vaginal tissue. Irradiated mucous tissue contracts and vaginal radius is reduced and it thus can embrace penis in a tighter manner when penetration during sexual intercourse takes place. Consequently, sensitivity is substantially improved and sexual intercourse results more pleasurable for both the woman and her partner. In a preferred embodiment, a diode laser source is used emiting at 1470 nm. In another embodiment, vagina's outer dimensions are accurately measured and surgery is performed to achieve dimensions according to certain aesthetic and functional criteria. Present method and device causes minimum pain and risk of side effects. Procedure is ambulatory and can be carried out in a physician's office.
The above and other objects, features and advantages of the present invention will become apparent from the following description read in conjunction with the accompanying drawings. Brief Description of the Drawings
FIG. 1 Depicts a diagram of a preferred embodiment of present invention showing main comprising parts of laser system.
FIG. 2 Shows a diagram of one embodiment of special applicator device for irradiation within the vagina.
FIG. 3 Represents the "clock needle" positions of the tissue to be treated.
FIG. 4 Shows a diagram of another embodiment of special applicator devi ce for irradiation within the vagina.
FIG. 5 Illustrates the geometric relationship that defines the Golden Ratio.
FIG. 6 Illustrates an example of the ideal location of the clitoris hood as a function of other parts of the female vagina.
Detailed Description of Preferred Embodiments
The present invention comprises a series of medical devices and treatments performed on the inside and the outside of a woman's vagina, based on the patient's expectations concerning quality of life, considering her physical health, psychological state, level of independence and social relations. Treatment is aimed mainly at women who have lost the normal shape of her genitals due to complicated labor, muscular dehiscence, or muscular tear, leading to loss of normal physiological conditions and a considerably decreased sexual response. Treatment is also aimed at women who wish to increase their self-esteem by aesthetically improving the looks of their vagina. Devices, method and criteria to achieve this are proposed without the drawbacks and limitations present in prior art.
After giving birth one or more times, women's vaginas become dilated or relaxed. The muscles are relaxed and have poor tone, strength, and control. During intercourse, dilated vaginas cannot embrace the penetrating penis properly and therefore sexual pleasure is diminished for both partners. Another important medical condition suffered by women with relaxed vaginas is vaginal prolapse, which can lead to other complications such as urinary incontinence. Applying laser energy within the vagina causes retraction of the mucosa, reducing its diameter by 15-20%. If the right energy is applied in certain places, it enhances pleasure during sexual intercourse or improves conditions like vaginal prolapse.
In a preferred embodiment, controlled vaginal hyperthermia (CVH) with a fiber optic medical treatment system is applied to enhance sexual gratification on women who for whatever reason lack an overall optimum architectural integrity of the vagina. Figure 1 depicts a laser based system 100 comprising laser source 102 which emits at a suitable wavelength through fiber optics device 104 radiating from its distal end 106 essentially perpendicular to the fiber axis. The type of optical fiber emission is chosen according to desired type of effect on tissue precision needed, maneuverability and convenient type of emitting pattern. Fibers used include a 360-degree radial fiber, a side firing fiber, an off-axis fiber or a twister fiber. In a preferred embodiment a cylindrical penis-shaped accessory (applicator device) 108 is inserted inside vagina and is used such that fiber 104 emits radiation from within applicator/dilator 108 to assure accurate, safe and even radiation on vagina wall 110. Technique is preferably carried out with a low energy laser device operating at a preselected laser wavelength of about 1470 + 60 nm. The water content in target tissue assures high absorption of this wavelength and thus desired contraction effects with low energy values. In other embodiments different wavelengths are chosen, such as about 980 + 30 nm when, for example deeper tissue penetration is desired. Combinations of these two wavelengths as an example are beneficial when ablation and effectively deeper treatment of the tissue is needed in rejuvenation or corrective surgery.
Figure 2 shows applicator device previously mentioned, an essential instrument of a preferred embodiment of present invention used to assure procedure can be carried out accurately and safely. Applicator 200 comprises a specially designed cylindrical element, round-shaped or penis-shaped at insertion end 212 for easy placement into a vagina and a flat end at maneuvering end 214 preferably with a flap handle 216 for easy handling- Applicator 200 is longitudinally hollowed in the middle forming an inner hollow tube 218 such that an optical fiber 204 may be inserted up to about 7 cm into it. The vagina's internal mucous lining 210 (tunica mucosa) is irradiated from the inside using a side-firing fiber 204 at a 1470 nm wavelength at desired portions while avoiding irradiation of sensitive parts. In other preferred embodiments, inner tube 218 has a non-circular section, for example elliptical, rectangular or star-shaped. In this case, optical fiber is installed inside a hand piece holder with a similar section shape and size. This serves two purposes. First of all, it helps maintain fiber steady when applying radiation. Secondly, it prevents use of other commercially existing fibers not intended for application to this type of treatment, thus assuring patient safety.
Figure 3 represents the "clock needle" positions of the circumference 300 from which selected areas are to be irradiated. Target portions are located at 2 o'clock 320, 4 o'clock 322, 8 o'clock 324 and 10 o'clock 326. Portion between 10 o'clock 326 and 2 o'clock 320 must be avoided to protect the bladder. Portion between 4 o'clock 322 and 8 o'clock 324 must be avoided to protect the intestines. Thus, applying laser energy in the correct places causes controlled retraction of the mucosa in desired portions with minimal damage to underlying sensitive tissue and reduces a vagina's diameter.
Figure 4a depicts another embodiment of essential applicator instrument of present invention used to assure procedure ca be carried out accurately and safely. Figure 4b represents a cross section of applicator 400. It comprises a specially designed cylindrical element 400, round-shaped or penis-shaped at insertion end 412 for easy placement into vagina and flat at maneuvering end 414 preferably with a flap 416 for easy handling. Applicator 400 is longitudinally hollowed in the middle forming an inner hollow tube 418 such that an optical fiber 404 may be inserted up to about 7 cm into it. A 360-degree radial emitting fiber or a side-firing fiber 404 is preferably used. As shown previously in Figure 3. there are up to 4 longitudinal portions that should be irradiated, while other parts need to be preserved. Applicator 400 is designed such that its surface is transparent to light in places corresponding to target tissue areas 420 but opaque in the rest of the surface so that sensible organs are not reached by laser irradiation. Thus, a radial emitting fiber 404 is inserted through applicator 400 made of a material such that light goes through only transparent longitudinal canals 422 but is either reflected or absorbed in the rest of cylinder's internal wall.
In a preferred embodiment, controlled vaginal hyperthermia (CVH) procedure consists of placing patient in gynecological position and introducing inside vagina an applicator device such as previously described Figure 2 or Figure 4. Next, fiber is introduced up to distal end of area to be treated. Additional elements such as a speculum can be used to aid in properly viewing treated area. Then, dilator is rotated to desired position and proper lasing parameters are set. Finally, laser energy is applied while fiber optic is withdrawn at a predetermined constant speed. After treatment, patient is encouraged to use a vaginal exerciser for a few days after surgery to prevent unwanted tissue collapse.
In another preferred embodiment, optical fiber is connected to an automatic pull-back system or device such as a step motor. This allows physician to assure withdrawal speed is constant, making procedure safer and more accurate.
In another preferred embodiment, applicator comprises an additional channel for insertion of an imaging system such as an endoscopic device, for online, real time monitoring of the procedure. An endoscopic device can also be incorporated through use of a shaped inner channel (hollow tube) to position both the endoscope and the fiber relative to one another in the main inner channel
To further illustrate the present invention, the following example describes a device and procedure which has rendered positive tissue retraction results on women patients desiring enhancement of their sexual relations.
Example: A diode laser based system emitting at a wavelength of 1470 nm was employed for controlled vaginal hyperthermia. Applicator is made of solid quartz, 3.5 cm in diameter and 10 cm long. It is flat on one end and rounded (penis-shaped) on the other end. It has a 7 cm long inner elliptical-shaped hollow tube in the middle with a transverse diameter of 2 mm and a conjugate diameter of 1 cm. Hand piece holder with a similar section shape and size and with a side-firing optical fiber fixed inside can fit inside hollow tube but does not allow fiber to rotate. Laser power is set at 10 Watts and emitted while fiber is withdrawn at a rate of 0.33 cm/s with firing end of fiber successively pointing at 4 o'clock, and at 10 o'clock. Endoscopic imaging after treatment showed a 5 mm thick white line along each lased portion of vaginal mucosa. Patient was instructed to not have sexual intercourse for the next 7 days. After a period of 45 days, lased portions retract and thus vaginal diameter is reduced. Another area which can benefit from the device and procedure of the present invention is Vaginoplasty with laser radiation, which comprises enhancement of vulvar structures, namely labia minora, labia majora, mons veneris, vaginal aperture and hymen. Examples of treatments that comprise surgery are:
Reducti ve labiaplasty and reduction of excess clitoral hood procedures allow for reducing hypertrophy of labia minora, and correcting asymmetric labia.
Perineoplasty rejuvenates the perineum which has lost its tone, and improves the sagging labia majora and labia minora. This procedure aims to make the vulva look younger.
The device used is similar than the used in earlier examples/descriptions. Practitioners select optimally tipped fibers for use with given applicators and desired irradiation geometry. The power levels are similar for primarily denaturing tissue, though ablation would use somewhat higher power and/or longer exposure to deposit more energy and achieve the desired amount of ablative tissue.
Furthermore, vaginal relaxation causes other important medical conditions, such as prolapsed vaginal or pelvic areas, which are also beneficially treated by the present invention. A vaginal prolapse is a condition in which structures such as the uterus, rectum, bladder, urethra, small bowel, or the vagina itself may begin to prolapse, or fall out of their normal positions. Without medical treatment or surgery, these structures may eventually prolapse farther and farther into the vagina or even through the vaginal opening if their supports weaken enough. In their extreme they can become life-threatening. The symptoms that result from vaginal prolapse commonly affect sexual functions and bodily functions such as urination and defecation. Pelvic pressure and discomfort are also common symptoms.
Urinary incontinence is a common symptom of this condition. In a preferred embodiment, minimally invasive surgery using 1470 nm laser radiation is applied to correct such medical conditions.
The overall objective is to treat the vagina so that it recovers its normal anatomy and physiology to achieve normal biological functions, improved external aspects and enhanced sexual gratification. Treatment is ambulatory and lasts a few minutes. Laser technique with 1470 nm or 980 nm wavelength and an off-axis or radially emitting fiber and protective device assures a precise treatment with minimal bleeding, effective scaring and essentially no complications or side effects. Final result is reconstruction of the most important part of the vagina for sexual pleasure, which is its lower third. Muscles and fascia are strengthened, thus improving vaginal muscular tone, strength and control. Excess vaginal mucosa is removed and the internal and external diameters of the vagina are reduced. Two of the enhanced areas are directly or indirectly involved with areas that help produce an orgasm. One is the perineum, which is completely reconstructed, augmenting its potential for producing an orgasm. The other is the superior portion of the orgasmic platform, which contains the G-spot from which intense sexual pressure sensations derive.
In a preferred embodiment, surgery is aimed at recovering the harmony, proportion and symmetry of female genitalia by means of a determined consensus regarding aesthetic criteria such as the Binet Formula and the divine proportions of Vitruvius. Thus, the concept of φ, also named the aurial number, golden number or divine section, is considered to obtain optimal proportions of the vulva. This concept has been used by historically known geniuses such as Salvador Dali in his paintings and Leonardo Da Vinci in his works. In mathematics and the arts, two quantities are in the golden ratio if the ratio of the sum of the quantities to the larger quantity is equal to the ratio of the larger quantity to the smaller one. The golden ratio is an irrational mathematical constant, approximately 1.6180339887.
Figure 5 illustrates the geometric relationship that defines this constant. Expressed algebraically:
a + b a
bb
This equation has as its unique positive solution, the algebraic irrational number
.6180339887. . .
The golden section is a line segment divided according to the golden ratio: The total length a + b is to the longer segment, a, as a is to the shorter segment, b.
Figure 6 depicts an example of how, sequentially from A to D the ideal location of the clitoris hood is graphically located as a function of other parts of the female vagina.
Having described preferred embodiments of the invention with reference to the accompanying drawings, it is to be understood that the invention is not limited to the precise embodiments, and that various changes and modifications may be effected therein by skilled in the art without departing from the scope or spirit of the invention as defined in the appended claims.

Claims

What is claimed is:
1 ) A fiber optic medical treatment system for irradiating female genitalia.
2) The fiber optic medical treatment system according to claim 1, further comprising: at least one laser source capable of producing radiation at a preselected wavelength, a power level and a power density to irradiate human tissue;
at least one optical fiber optically coupled to said laser source and capable of transmitting said radiation from said laser source from proximal end to distal end of said optical fiber;
a handpiece coupled to said at least one optical fiber to aid in transmitting said radiation from distal end of said optical fiber to said human tissue; and
an applicator device capable of allowing or preventing transmission of said radiation onto specific target or protected areas respectively.
3) The medical treatment system according to any of claims 1 to 2, wherein said
preselected wavelength is selected from the group of about 1470 ±60 nm and about 980 +30 nm or a combination of them.
4) The medical treatment system according to any of claims 1 to 3, wherein said optical fiber is selected from the group of radial fibers, side firing fibers, twister fibers and off-axis fibers.
5) The medical treatment system according to any of claims 1 to 4, wherein said
applicator device is rounded at insertion end.
6) The medical treatment system according to any of claims 1 to 5, wherein said
applicator device further comprises a longitudinal inner hollow tube for said optical fiber insertion.
7) The device according to claim 6, whereby said inner hollow tube allows for insertion of a specifically shaped optical fiber.
8) The medical treatment system according to any of claims 1 to 7, wherein said
applicator device further comprises a canal for insertion of endoscopic imaging systems.
9) The medical treatment system according to any of claims 1 to 8, wherein said
applicator device further comprises
at least one area transparent to laser radiation; and
at least one area that absorbs laser radiation. 10) The medical treatment system according to any of claims 1 to 9, further comprising an automatic pullback device capable of withdrawing said optical fiber at a constant speed.
11) A medical system to enhance female sexual response accordmg to any of claims 1 to 10 wherein said laser radiation is applied to inside and outside parts of a vagina and laser radiation ablates tissue in labiaplasty; perineoplasty; clitoral hood reduction; and vaginoplasty procedures.
12) The medical system to enhance female sexual response according to claim 11,
wherein said laser system ablates tissue in vaginoplasty procedures includes a protective device inside vagina, having a fiber optic inside protective device prior to applying laser radiation.
13) A medical system according to any of claims 1 to 10 to enhance aesthetics of female genitalia wherein laser radiation is applied to said genitalia to modify said genitalia's external appearance by measuring relative proportions of parts of said genitalia;
applying The Golden Ratio as objective criteria for said genitalia's ideal said proportions; and surgically modifying said genitalia to achieve said ideal proportions.
14) A medical system according to any of claims 1 to 10 whereby laser radiation is applied internally to female genitalia for use in vaginal prolapsed and urinary incontinence treatments
PCT/US2011/067938 2010-12-29 2011-12-29 Vaginal remodeling/rejuvenation device and method WO2012092508A2 (en)

Priority Applications (6)

Application Number Priority Date Filing Date Title
EP11852256.4A EP2658465B1 (en) 2010-12-29 2011-12-29 Vaginal remodeling/rejuvenation device
CN2011800638337A CN103281984A (en) 2010-12-29 2011-12-29 Vaginal remodeling/rejuvenation device and method
MX2013007234A MX349589B (en) 2010-12-29 2011-12-29 Vaginal remodeling/rejuvenation device and method.
AU2011352059A AU2011352059A1 (en) 2010-12-29 2011-12-29 Vaginal remodeling/rejuvenation device and method
BR112013016337A BR112013016337A2 (en) 2010-12-29 2011-12-29 fiber optic medical treatment system
US13/997,554 US10687894B2 (en) 2010-12-29 2011-12-29 Vaginal remodeling/rejuvenation device and method

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US201061428023P 2010-12-29 2010-12-29
US61/428,023 2010-12-29
US201161481974P 2011-05-03 2011-05-03
US61/481,974 2011-05-03

Publications (2)

Publication Number Publication Date
WO2012092508A2 true WO2012092508A2 (en) 2012-07-05
WO2012092508A3 WO2012092508A3 (en) 2012-11-01

Family

ID=46383866

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2011/067938 WO2012092508A2 (en) 2010-12-29 2011-12-29 Vaginal remodeling/rejuvenation device and method

Country Status (7)

Country Link
US (1) US10687894B2 (en)
EP (1) EP2658465B1 (en)
CN (2) CN109288585B (en)
AU (3) AU2011352059A1 (en)
BR (1) BR112013016337A2 (en)
MX (1) MX349589B (en)
WO (1) WO2012092508A2 (en)

Cited By (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20130006334A1 (en) * 2010-02-04 2013-01-03 Mauro Galli Device for the treatment of the vaginal canal and relevant equipment
CN103211651A (en) * 2013-04-23 2013-07-24 重庆德马光电技术有限公司 Laser therapeutic instrument for vagina tightening
ES2529390A1 (en) * 2014-07-11 2015-02-19 Intermedic Arfran, S.A. Device for the treatment of a tissue by laser radiation (Machine-translation by Google Translate, not legally binding)
EA025132B1 (en) * 2014-08-28 2016-11-30 Наталья Валерьевна Мороз Method for low-invasive perineal plastics
WO2020003086A1 (en) * 2018-06-26 2020-01-02 Zlasers Ltd. Vaginal tightening and treatment of wrinkles
JP2020501686A (en) * 2016-12-14 2020-01-23 クリニカル レーザーサーミア システムズ アクチエボラグ Apparatus and method for controlling laser hyperthermia
US11896823B2 (en) 2017-04-04 2024-02-13 Btl Healthcare Technologies A.S. Method and device for pelvic floor tissue treatment

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9713565B2 (en) * 2014-06-20 2017-07-25 Chongqing Peninsula Medical Technology Co., Ltd. Virginal rejuvenation apparatus and method
CN105796048B (en) * 2016-05-26 2017-05-24 顾瑛 Detachable vaginal speculum suitable for photodynamic therapy
USD829922S1 (en) 2017-05-12 2018-10-02 Filip Sedic Vaginal rejuvenation device

Family Cites Families (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5242437A (en) * 1988-06-10 1993-09-07 Trimedyne Laser Systems, Inc. Medical device applying localized high intensity light and heat, particularly for destruction of the endometrium
US5468239A (en) * 1992-04-13 1995-11-21 Sorenson Laboratories, Inc. Apparatus and methods for using a circumferential light-emitting surgical laser probe
US5303719A (en) * 1992-08-14 1994-04-19 Wilk Peter J Surgical method and associated instrument assembly
IL104100A (en) * 1992-12-15 1997-11-20 Laser Ind Ltd Device for treating the interior of body cavities with laser energy
US5478339A (en) * 1994-08-30 1995-12-26 The Regents Of The University Of California Intrauterine device for laser light diffusion and method of using the same
JP3551996B2 (en) * 1995-08-25 2004-08-11 松下電器産業株式会社 Medical laser probe
US6013053A (en) * 1996-05-17 2000-01-11 Qlt Photo Therapeutics Inc. Balloon catheter for photodynamic therapy
US6471692B1 (en) * 1998-06-24 2002-10-29 Laser Industries Ltd. System and method for manipulating movement of an energy emitting device within a body cavity
DE602004011696T2 (en) * 2003-03-27 2009-02-19 Terumo K.K. Medical irradiation device
US8257411B2 (en) * 2003-09-30 2012-09-04 Biolitec Pharma Marketing Ltd Method for treatment of varices
US7544204B2 (en) * 2003-10-15 2009-06-09 Valam Corporation Control of halitosis-generating and other microorganisms in the non-dental upper respiratory tract
US20050197682A1 (en) * 2004-03-02 2005-09-08 Sherry Fox Method and apparatus for treating erectile sexual dysfunction using light energy
WO2005120379A2 (en) * 2004-06-07 2005-12-22 Edwards Lifesciences Corporation Methods and devices for delivering ablative energy
TWI268787B (en) * 2004-12-30 2006-12-21 Ind Tech Res Inst Light therapeutic device
ES2668959T3 (en) * 2005-03-31 2018-05-23 Esther Mayer Probe device for tissue photobiomodulation that covers a body cavity
US8801764B2 (en) * 2005-05-05 2014-08-12 Biolitec Pharma Marketing Ltd Cosmetic laser treatment device and method for localized lipodystrophies and flaccidity
US7749162B2 (en) * 2005-09-29 2010-07-06 Forth Photonics Ltd. Vaginal speculum arrangement
BRPI0713109A2 (en) * 2006-06-27 2012-10-16 Palomar Medical Tech Inc manual photocosmetic device
US8292935B2 (en) * 2006-09-12 2012-10-23 Bistitec Pharma Marketing Ltd Photonic device and method for treating cervical dysplasia
US20100030020A1 (en) * 2006-10-20 2010-02-04 Femsuite Llc Optical surgical device and method of use
US9693826B2 (en) * 2008-02-28 2017-07-04 Biolitec Unternehmensbeteiligungs Ii Ag Endoluminal laser ablation device and method for treating veins
US9289262B2 (en) * 2008-05-19 2016-03-22 Boston Scientific Scimed, Inc. Dielectric coatings for laser fiber and related methods
US8795264B2 (en) * 2008-07-01 2014-08-05 Ralph Zipper Method for decreasing the size and/or changing the shape of pelvic tissues
US20100036259A1 (en) * 2008-08-05 2010-02-11 Dicarlo Paul Uterine Infrared Thermal Imaging Device
US8574177B2 (en) * 2010-03-11 2013-11-05 Bwt Property, Inc. Phototherapy and massage apparatus for treating medical conditions in body cavities
US8696561B2 (en) * 2010-04-01 2014-04-15 Tamatha Britt Fenster LEEP safety guard
US8936592B2 (en) * 2010-06-03 2015-01-20 Ams Research Corporation Laser tissue ablation system
US10213260B2 (en) * 2011-12-01 2019-02-26 Joe Denton Brown End fire fiber arrangements with improved erosion resistance
US20180008837A1 (en) * 2016-07-11 2018-01-11 Jack K. Zhang Light therapy delivery devices and methods for the female genitalia and areas proximal thereto

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
See references of EP2658465A4 *

Cited By (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20160184015A1 (en) * 2010-02-04 2016-06-30 El. En. S.P.A. Device and method for the treatment of the vaginal canal and relevant equipment
US9867666B2 (en) * 2010-02-04 2018-01-16 El. En. S.P.A. Device and method for the treatment of the vaginal canal and relevant equipment
US20130006334A1 (en) * 2010-02-04 2013-01-03 Mauro Galli Device for the treatment of the vaginal canal and relevant equipment
CN103211651A (en) * 2013-04-23 2013-07-24 重庆德马光电技术有限公司 Laser therapeutic instrument for vagina tightening
WO2016005622A1 (en) * 2014-07-11 2016-01-14 Intermedic Arfran, S.A. Device for the treatment of a tissue by means of laser radiation
ES2529390A1 (en) * 2014-07-11 2015-02-19 Intermedic Arfran, S.A. Device for the treatment of a tissue by laser radiation (Machine-translation by Google Translate, not legally binding)
EA025132B1 (en) * 2014-08-28 2016-11-30 Наталья Валерьевна Мороз Method for low-invasive perineal plastics
JP2020501686A (en) * 2016-12-14 2020-01-23 クリニカル レーザーサーミア システムズ アクチエボラグ Apparatus and method for controlling laser hyperthermia
EP3335660B1 (en) * 2016-12-14 2021-01-20 Clinical Laserthermia Systems AB Apparatus for controlling laser thermotherapy
JP7231936B2 (en) 2016-12-14 2023-03-02 クリニカル レーザーサーミア システムズ アクチエボラグ Apparatus and method for controlling laser hyperthermia
US11896823B2 (en) 2017-04-04 2024-02-13 Btl Healthcare Technologies A.S. Method and device for pelvic floor tissue treatment
WO2020003086A1 (en) * 2018-06-26 2020-01-02 Zlasers Ltd. Vaginal tightening and treatment of wrinkles
US10765883B2 (en) 2018-06-26 2020-09-08 Zlasers Ltd. Vaginal tightening and treatment of wrinkles

Also Published As

Publication number Publication date
MX2013007234A (en) 2013-08-15
CN109288585A (en) 2019-02-01
WO2012092508A3 (en) 2012-11-01
AU2018236700A1 (en) 2018-10-18
US10687894B2 (en) 2020-06-23
BR112013016337A2 (en) 2018-02-14
CN103281984A (en) 2013-09-04
AU2011352059A1 (en) 2013-07-11
US20140343540A1 (en) 2014-11-20
EP2658465B1 (en) 2019-05-22
EP2658465A4 (en) 2014-06-25
CN109288585B (en) 2022-06-17
MX349589B (en) 2017-08-04
EP2658465A2 (en) 2013-11-06
AU2016259422A1 (en) 2017-01-05

Similar Documents

Publication Publication Date Title
EP2658465B1 (en) Vaginal remodeling/rejuvenation device
Karcher et al. Vaginal rejuvenation using energy-based devices
EP2476460B1 (en) Laser system for non ablative treatment of mucosa tissue
US10039929B1 (en) Method and device for pelvic floor tissue treatment
AU2016324168B2 (en) Methods and systems for treating urinary stress incontinence
US20100286576A1 (en) Photo Therapy and Massage Apparatus for Relieving Pain in Body Cavities
JP2002519162A (en) Method and apparatus for stimulating the immune system and generating healing at the cellular level
US11564861B1 (en) Method for treating erectile and sexual dysfunction with dual extracorporeal shockwave therapy
KR20160012851A (en) High intensity focused ultrasound operating apparatus and operating method thereof
US20180214304A1 (en) Devices for dual mechanism aesthetic treatment and methods of use thereof
US20230321435A1 (en) Methods for treating urinary stress incontinence
Hunner THE TREATMENT OF LEUCORRHEA WITH THE ACTUAL CAUTERY.
US20090005767A1 (en) Device and method for benign prostatic hyperplasia laser treatment
Scott et al. Treatment of condyloma acuminata with carbon dioxide laser: A prospective study
Hart et al. The alternatives to hysterectomy
Fried et al. Therapeutic Applications of Lasers
Ye et al. Use of a new local anesthesia–Intracorpus spongiosum anesthesia–In procedures on anterior urethra
Minaev Laser apparatus for surgery and force therapy based on high-power semiconductor and fibre lasers
RU2367487C1 (en) Method of fractionated photodynamic therapy of benign prostate hyperplasia
US11819689B1 (en) Method for treating erectile and sexual dysfunction with focused extracorporeal shockwave therapy
Garg et al. Vaginal Rejuvenation
RU2226078C1 (en) Method for performing vaginoplastic repair
Toledano Energy-Based Devices: Comparisons and Indications
Pancholia et al. Other Lasers in Aesthetic and Regenerative Gynecology
Kaplan The CO2 laser as a versatile surgical modality

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 11852256

Country of ref document: EP

Kind code of ref document: A2

WWE Wipo information: entry into national phase

Ref document number: MX/A/2013/007234

Country of ref document: MX

NENP Non-entry into the national phase

Ref country code: DE

ENP Entry into the national phase

Ref document number: 2011352059

Country of ref document: AU

Date of ref document: 20111229

Kind code of ref document: A

WWE Wipo information: entry into national phase

Ref document number: 2011852256

Country of ref document: EP

REG Reference to national code

Ref country code: BR

Ref legal event code: B01A

Ref document number: 112013016337

Country of ref document: BR

ENP Entry into the national phase

Ref document number: 112013016337

Country of ref document: BR

Kind code of ref document: A2

Effective date: 20130625